In line with this, recent studies using single cell RNA sequencing have revealed that distinct subsets of CD4+ T cells are considered to be an essential contributing factor in the immune landscape of IBD despite heterogeneity of T cells (6–8). The gene discussed is CD4; the disease is inflammatory bowel disease.